NCT05160064

Long-term Registry of Patients Treated With Loncastuximab Tesirine

Long-term Longitudinal Cohort Registry of Patients Treated With Loncastuximab Tesirine

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: ADC Therapeutics S.A. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Retrospective and prospective multi-center observational study of patients with B-cell lymphomas treated with loncastuximab tesirine treatment in real-world practice.

Detailed description

The purpose of this study is to assess treatment patterns and generate evidence on the effectiveness and safety of loncastuximab tesirine treatment in real-world practice. This clinical trial information was submitted voluntarily under the applicable law and, therefore, certain submission deadlines may not apply. (That is, clinical trial information for this applicable clinical trial was submitted under section 402(j)(4)(A) of the Public Health Service Act and 42 CFR 11.60 and is not subject to the deadlines established by sections 402(j)(2) and (3) of the Public Health Service Act or 42 CFR 11.24 and 11.44.).

Conditions

• B-Cell Lymphomas

Timeline

• Start date: 2022-06-30
• Primary completion: 2024-12-01
• Completion: 2025-01-01
• First posted: 2021-12-16
• Last updated: 2022-06-22

Locations

1 site across 1 country: United States